CQDM

Consortium sur la découverte du médicament Navigation
  • HOME
  • ABOUT
    • MISSION, VISION AND IMPACT
    • STRUCTURE AND GOVERNANCE
    • TEAM
    • MEMBERS
    • COLLABORATORS
    • REPORTS
    • 10th ANNIVERSARY
  • PROGRAMS
    • QUANTUM LEAP
    • SYNERGIQC
    • MENTORSHIP
    • INNOVATION-IA
    • COMPLETED PROGRAMS
  • FUNDED PROJECTS
  • NEWS
  • Contact
  • FR
  • SPECIAL INITIATIVES
    • FACS
    • CATALIS
  • HOME
  • ABOUT
    • MISSION, VISION AND IMPACT
    • STRUCTURE AND GOVERNANCE
    • TEAM
    • MEMBERS
    • COLLABORATORS
    • REPORTS
    • 10th ANNIVERSARY
  • PROGRAMS
    • QUANTUM LEAP
    • SYNERGIQC
    • MENTORSHIP
    • INNOVATION-IA
    • COMPLETED PROGRAMS
  • FUNDED PROJECTS
  • NEWS
  • Contact
  • FR
  • SPECIAL INITIATIVES
    • FACS
    • CATALIS

Post Archive by Year

Announcement of an investment of close to $8 million dollars in biopharmaceutical research in Québec

Monday June 8th, 2009News & Events

Announcement of a new funding from the Government of Canada

Monday February 23rd, 2009News & Events

LATEST NEWS

  • CQDM welcomes Zymeworks as a new member of CQDM’s biopharmaceutical consortium
    Thursday February 27th, 2020
    Montreal, February 27, 2020 – CQDM is pleased to […]
  • CQDM partners with GlycoNet to support innovative Glycomics research in Canada
    Tuesday February 25th, 2020
    Montreal, Feb 25th, 2020 – CQDM and the Canadian […]
  • 2nd Annual Gordon Shore Prize – Postdoctoral Internships in the Biopharmaceutical Industry
    Monday February 17th, 2020
    Presented by CQDM, Diazon Pharmaceuticals and Mitacs, […]

About CQDM

  • Our Mission, Vision and Impact
  • Structure & Governance
  • Team
  • Members
  • Collaborators
  • Contact us

Programs

  • Quantum Leap
  • SynergiQc
  • SynergiQc-International
  • Mentorship
  • Completed Programs

Follow Us!

Tweets by @CQDM_Canada

© CQDM 2020 // Web: Draxo Marketing

We use cookies and other tracking technologies to improve your browsing experience on our website. By browsing our website, you consent to our use of cookies and other tracking technologies. Accept